WHO Grade 1 Glioma — Trials

WHO Grade 1 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

36 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07121829	Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors	terminated	Phase 1	44	Day One Biopharmaceuticals, Inc.INDUSTRY	2	Aug 14, 2025	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	terminated	Phase 1	129	National Cancer Institute (NCI)NIH	2	Nov 5, 2014	clinicaltrials
NCT00110032	Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors	terminated	Phase 1	46	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials

Data updated 23 days agoSource updated Aug 14, 2025source: clinicaltrials